Investorideas.com - Cannabis ETF News: AdvisorShares Announces Pure Cannabis Dividend Distribution
www.investorideas.com - news that inspires big ideas
Wednesday, 25 September 2019
Tuesday, 24 September 2019
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $GYSR.V) (TSX: $APHA.TO) (NYSE: $APHA) (TSX.V: $PURE.V) (OTC: $PRCNF)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV:
$GYSR.V) (TSX: $APHA.TO) (NYSE: $APHA) (TSX.V: $PURE.V) (OTC: $PRCNF)
Delta, Kelowna, BC –September 24 , 2019
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/09241GYSR-APHA-PURE-PRCNF.asp
Today's podcast overview/transcript
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts
In
today’s podcast we look at a few early announcements.
Geyser
Brands Inc. (formerly Kanzen Capital Corp.) (TSX-V: GYSR) announced the receipt of their Natural Product
Number (NPN) from Health Canada for their hemp-based pain relief roll-on.
Through the issuance of the NPN, Geyser Brands' Solace subsidiary (see press
release dated September 18, 2019) is authorized to market and sell their Pain
Relief Roll-on as a natural health product through the Apothecary Naturals line
of products. Licensed products have been assessed by Health Canada and found to
be safe, effective and of high quality under their recommended conditions of
use.
According to the Allied Market Research,
the global topical pain relief market garnered $7.48 billion in 2017, and is
expected to reach $13.28 billion by 2025, growing at a CAGR of 7.4% from 2018
to 2025. With distribution through traditional retailers and
direct-to-consumer, products are expected to hit shelves in October, 2019.
The
Solace subsidiary carries the Apothecary line of brands including:
Apothecary Naturals: 100% all-natural, organic, hemp-based
products for everything from skin care to pain relief.
Website: https://www.apothecarynaturals.ca/
Website: https://www.apothecarynaturals.ca/
Apawthecary Pets: 100% all-natural wellness products for pet
pain and anxiety.
Website: https://www.apawthecarypets.com/
Website: https://www.apawthecarypets.com/
Wildtails: 100% all-natural,
freeze-dried, single-ingredient and nano-hemp infused pet foods and treats.
Website: https://www.wildtailspet.com/
Website: https://www.wildtailspet.com/
Apothecary Ink: Antibacterial skin
preparation, pain control and skin care for new and old tattoos.
Website: https://www.apothecaryink.com
Website: https://www.apothecaryink.com
"Receiving
our NPN supports our vision to develop and build brands based on trust and
credibility in an emerging but heavily regulated industry. Our continued focus
on natural, healthy ingredients along with world-class formulations has been
recognized with this NPN and we look forward to rolling these out in Canada as
a first step in building a global presence", stated Geyser Brands
Chairman, Brad Kersch. "We have over 15,000 square feet of GMP-rated
manufacturing space and our plans are to increase our capacity significantly in
preparation for the next growth phase in the cannabis space,'' he added.
Aphria Inc. (TSX: APHA) (NYSE: APHA) today announced the launch of its cannabis education
program 'Aphria Educates'. This
program is mandated to educate Canadian adults on responsible and safe use of
all cannabis products legally available now and in the future.
The
first Aphria Educates event will be
a two-city educational panel in conjunction with Drugs Free Kids Canada (DFK),
a Canadian non-profit organization providing parents with evidence-informed
information about youth and substance use while promoting frequent, balanced
parent-youth discussions about drugs. Entitled Aphria Educates with Drug Free Kids Canada, the panels will focus
on furthering awareness around the potential harms of cannabis for youth and
help parents navigate the ever-evolving Canadian cannabis landscape.
The
Aphria Educates with Drugs Free Kids
Canada initiative follows the 2018 Charter Agreement entered into by Aphria
and DFK solidifying their commitment to ongoing cannabis education.
Comprised
of expert panelists from across the country, Aphria Educates with Drugs Free Kids Canada brings together thought
leaders from various organizations focused on education, including: Susan Hutt
from
Drug Free Kids Canada, Nikita Stanley and Aleks Jassem from
The Rebel Mama, and
Michelle Latinsky, Director of Education at Aphria Inc.
The
Aphria Educates with Drugs Free Kids
Canada panels will take place in Toronto on October 2nd and in
Vancouver on October 3rd.
"Cannabis
education is a cornerstone of our Corporate Social Responsibility platform and
is paramount in everything we do at Aphria Inc. We are proud to launch Aphria Educates, an engaging program that
is designed to educate on the safe and responsible use of legal cannabis,"
said Irwin D. Simon. "There is no better partner than Drug Free Kids
Canada to help kick off this first initiative of Aphria Educates, which we
believe will deliver important information and will encourage necessary dialogue
among Canadian parents and their children."
"With
the anticipated legalization of new recreational cannabis products, it's more
important than ever for us as parents to be equipped with information to
support helpful and fruitful conversations that can empower youth to make
healthy choices." said Susan Hutt, Community Programs Manager at Drug Free
Kids Canada. "Drug Free Kids Canada has been a leader in providing parents
with the knowledge they need to educate their kids about drugs. We're confident
the Aphria Educates with Drugs Free Kids Canada panel will help promote
evidence-based dialogue about cannabis and youth. The education program we have
developed alongside Aphria is industry leading and we are proud to take a place
in this important discussion."
Pure Global
Cannabis Inc. (TSX.V: PURE) (OTC: PRCNF) operating through its wholly-owned
subsidiary PureSinse Inc. announced the signing of a Joint Development
Agreement with KMT-Hansa Corp. in respect of the processing, extraction,
cultivation and manufacturing of hemp and related products across approximately
17,000 acres of land in the province of Yunnan. The Agreement will take
advantage of the Hemp International Industry Park Special Economic Zone License
granted to KMT by Yuanjiang County, Yuxi City, Yunnan Province, permitting the
growth, cultivation, extraction and production of industrial hemp products for
export. The license registration process is expected to complete within the
next 60 days while operations are setup.
Pure
Global will be the management and development partner in connection with the
Project, with KMT providing the necessary resources and personnel. Pure Global
will be responsible for the technology, know how, genetics and sales and
distribution of hemp products produced in connection with the Project. The
Company will design Good Manufacturing Practices compliant facilities and
manage the development and deployment of the Project while overseeing the
ongoing operations for the manufacturing and cultivation of high-quality hemp
products and by-products, including CBD. Pure will have the right of first
refusal to sell and distribute all manufactured products and by-products in all
international jurisdictions.
KMT
will be responsible for securing and maintaining all necessary permits and
licenses with the Chinese Government and Authorities to grow, extract, process
and export CBD and hemp by-products grown on the lands that have been
government sanctioned for the region's economic development.
Pure
Global's CEO & President Malay Panchal commented, "We are extremely
excited to be the first Canadian LP to partner with a Chinese group seeking to
develop a project of this scale in China. This strategic relationship gives us
access to KMT's resources and connections in China. They truly share our goal
of providing high-quality products that are sustainable to the environment and
developed using cutting-edge agricultural methods. We are extremely happy to
enter into this Agreement with a trusted partner who shares our values,
visions, and long-term goals. I was especially thrilled by the warm welcome we
received from the Chinese local, state, and federal authorities on our recent
visit and the tremendous support they are willing to offer to make this project
a success for all stakeholders."
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original financial
content. Learn about investing in stocks and
sector trends from
Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news release,
content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...